Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Depression 4Neoplasms 3Anxiety Disorders 3Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasm Metastasis 1Hematopoietic and Lymphatic System Neoplasm 1Gastrointestinal Neoplasms 1Depressive Disorder, Major 1Depressive Disorder 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Biliary Tract Neoplasms 1

Interventions

pembrolizumab 36Bevacizumab 25Cyclophosphamide 23Blood Specimen Collection 19Nivolumab 17Standard of Care 15Carboplatin 15Paclitaxel 14atezolizumab 13Gemcitabine 13Exercise 13Pemetrexed 11Fluorouracil 11Doxorubicin 11Cisplatin 11Cetuximab 10Radiotherapy 9Oxaliplatin 9Magnetic Resonance Spectroscopy 9Leucovorin 9Docetaxel 9130-nm albumin-bound paclitaxel 9durvalumab 8abemaciclib 8Temozolomide 8Surveys and Questionnaires 8Rituximab 8Prednisone 8Biopsy 8olaparib 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Neoplasms × Psilocybin × 90 days × Clear all
NCT05947383 2026-05-06

2Dose

Sunstone Medical

Phase 2 Active not recruiting
56 enrolled

Depression, Depressive Disorder, Major, Neoplasms

NCT06801041 2026-04-16

TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors

M.D. Anderson Cancer Center

Phase 2 Recruiting
20 enrolled

Anxiety Disorders, Depression, Neoplasms

NCT06319378 2026-04-13

CAPSI

Section for Affective Disorders; Northern Stockholm Psychiatry

Phase 2 Recruiting
100 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡